The American College of Chest Physicians (CHEST) is the global leader in advancing best patient outcomes through innovative chest medicine education, clinical research, and team-based care. CHEST 2022 features the latest clinical guidance, groundbreaking science, unique interactive experiences, and networking with leaders in chest medicine.
See our latest research, below. For more information about the conference, please visit https://www.chestnet.org/Learning-and-Events/Events/CHEST-Annual-Meeting.
4142 | Exacerbation Risk in COPD Patients Based on Eosinophil Count – Post Hoc Analysis of the Randomized Pragmatic Trial, AIRWISE, Comparing Tiotropium/Olodaterol with Triple Therapy
Mina B1, Averill F2, Shaikh A3, Bayer V3, Voss F4, Drda K3, Gongwer R5, Kato B5, Willey V5
1Zucker School of Medicine at Hofstra University, New York, NY, USA, 2St. Francis Sleep, Allergy & Lung Institute, Clearwater, FL, USA, 3Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA, 4Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany, 5HealthCore, Inc., Wilmington, DE, USA
*HealthCore authors are indicated in bold.